文献速递生殖医学

不同避孕方式对计划性卵母细胞冷冻保存患者卵母细胞获数与成熟度的影响

Effect of various contraceptives on oocyte yield and maturation in patients undergoing planned oocyte cryopreservation.
PubMed 文献 · Reprod Biomed Online · 2024-05-07

这项回顾性队列研究纳入2011年至2023年间接受计划性卵母细胞冷冻保存(POC)的4059个周期,比较8种避孕方式与对照组在卵母细胞获数和成熟率上的差异。各队列间获卵母细胞复合体中位数相当(P=0.054),卵母细胞成熟率及玻璃化卵母细胞中位数存在显著差异(P=0.03,P<0.001),但多因素分析校正混杂因素后,避孕方式与可冷冻的MII卵母细胞比例无关联。结论认为各种避孕方式均未显示对POC患者的卵母细胞获数或成熟率有不良关联。

要点

  • 4059个POC周期中,复方口服避孕药最常见(n=2349),对照组n=1220。
  • 各避孕队列获卵母细胞复合体中位数相当(P=0.054)。
  • 校正混杂后避孕方式与可冷冻MII卵母细胞比例无关联。

核心结论

  • 在各种避孕方式中,均未显示对接受POC患者的卵母细胞获数或成熟率有不良关联。

研究设计与样本

  • 回顾性队列研究,纳入2011年至2023年间接受POC周期的所有患者,共4059个卵母细胞冷冻周期。
  • 记录POC周期前使用的避孕方式类型,评估阴道取卵后获得的卵丘-卵母细胞复合体中位数及所有队列中玻璃化的MII卵母细胞比例。

主要发现

  • 共识别8种避孕方式:宫内节育器(IUD)铜(n=84)、IUD左炔诺孕酮低剂量(<52 mg)(n=37)、IUD左炔诺孕酮(n=192)、皮下依托孕烯植入剂(n=14)、注射甲羟孕酮醋酸酯(n=11)、依托孕烯阴道环(n=142)、复方口服避孕药(n=2349)、诺孕曲明透皮贴剂(n=10);对照组为不使用避孕药或使用屏障/日历法者(n=1220)。
  • 所有队列间取卵时获得的卵丘-卵母细胞复合体中位数相当(P=0.054)。
  • 所有队列间卵母细胞成熟率及玻璃化卵母细胞中位数存在显著差异(P=0.03,P<0.001)。
  • 校正混杂因素后,多因素分析发现避孕方式类型与可冷冻的MII卵母细胞比例之间无关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Do the various forms of hormonal and non-hormonal contraceptives have any association with ovarian stimulation outcomes, such as oocyte yield and maturation, in patients undergoing planned oocyte cryopreservation (POC)? DESIGN: This retrospective cohort study included all patients who underwent POC cycles between 2011 and 2023. The use of types of contraception before a POC cycle was recorded. The study evaluated the median number of cumulus-oocyte complexes obtained after vaginal oocyte retrieval and the proportion of metaphase II oocytes that underwent vitrification among all the cohorts. RESULTS: A total of 4059 oocyte freezing cycles were included in the analysis. Eight types of contraceptive method were recognized in patients undergoing ovarian stimulation: intrauterine device (IUD), copper (n = 84); IUD, levonorgestrel low dose (<52 mg) (n = 37); IUD, levonorgestrel (n = 192); subdermal etonogestrel implant (n = 14); injectable medroxyprogesterone acetate (n = 11); etonogestrel vaginal ring (n = 142); combined oral contraceptive pills (n = 2349); and norelgestromin transdermal patch (n = 10). The control group included patients not using contraceptives or using barrier or calendar methods (n = 1220). Among all the cohorts the median number of cumulus-oocyte complexes retrieved during oocyte retrieval was comparable (P = 0.054), and a significant difference in oocyte maturity rate with median number of vitrified oocytes was found (P = 0.03, P < 0.001, respectively). After adjusting for confounders a multivariate analysis found no association between the type of contraceptive and proportion of metaphase II oocytes available for cryopreservation. CONCLUSIONS: Among the various forms of contraception, none was shown to have an adverse association with oocyte yield or maturation rate in patients undergoing POC.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Hernandez-Nieto C, Siddiqui S, Mejia-Fernandez L, et al. Effect of various contraceptives on oocyte yield and maturation in patients undergoing planned oocyte cryopreservation. Reprod Biomed Online. 2024. PMID: 38986195. doi:10.1016/j.rbmo.2024.104105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。